Zdrowie i gospodarka · 27/08/2019
FDA Announces Draft Guidance for Developing Drugs for Male Breast Cancer Treatment
The FDA is releasing a draft guidance for the pharmaceutical industry on developing and labeling cancer drugs for male breast cancer patients, aiming to improve treatment options and clinical management of the disease.
Source: Federal Register — Food and Drug AdministrationOpen original release →